FC

Felix Cleemann

AA Ascendis Pharma Growth Disorders A/S: 4 patents #3 of 9Top 35%
Overall (2022): #49,745 of 548,613Top 10%
4
Patents 2022

Issued Patents 2022

Showing 1–4 of 4 patents

Patent #TitleCo-InventorsDate
11413351 CNP prodrugs with carrier attachment at the ring moiety Harald Rau, Ulrich Hersel, Caroline Elisabeth Rasmussen 2022-08-16
11389510 Controlled-release CNP agonists with low initial NPR-B activity Kennett Sprogøe, Harald Rau, Ulrich Hersel, Caroline Elisabeth Rasmussen 2022-07-19
11389511 Controlled-release CNP agonists with reduced side-effects Kennett Sprogøe, Harald Rau, Ulrich Hersel, Caroline Elisabeth Rasmussen 2022-07-19
11311604 Controlled-release CNP agonists with low NPR-C binding Harald Rau, Ulrich Hersel, Kennett Sprogøe, Frank Faltinger, Thomas Wegge 2022-04-26